JPS5952000B2 - Novel physiologically active substance 3-deoxyafuidicorin and its production method - Google Patents

Novel physiologically active substance 3-deoxyafuidicorin and its production method

Info

Publication number
JPS5952000B2
JPS5952000B2 JP10073082A JP10073082A JPS5952000B2 JP S5952000 B2 JPS5952000 B2 JP S5952000B2 JP 10073082 A JP10073082 A JP 10073082A JP 10073082 A JP10073082 A JP 10073082A JP S5952000 B2 JPS5952000 B2 JP S5952000B2
Authority
JP
Japan
Prior art keywords
culture
deoxyaphidicolin
deoxyafuidicorin
active substance
physiologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP10073082A
Other languages
Japanese (ja)
Other versions
JPS58220689A (en
Inventor
英秋 及川
貞雄 坂村
耿民 市原
和子 林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd filed Critical Asahi Chemical Industry Co Ltd
Priority to JP10073082A priority Critical patent/JPS5952000B2/en
Publication of JPS58220689A publication Critical patent/JPS58220689A/en
Publication of JPS5952000B2 publication Critical patent/JPS5952000B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

【発明の詳細な説明】 本発明は、真核細胞DNAポリメラーゼαの特異的阻害
活性を有する新規な生理活性物質3−デオキシアフイデ
イコリンならびにその製造法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel physiologically active substance 3-deoxyaphidicolin having specific inhibitory activity on eukaryotic DNA polymerase α and a method for producing the same.

この発明の目的物質である3−デオキシアフイデイコリ
ンは、次の構造式(I)で示される。
3-deoxyaphidicolin, which is the target substance of this invention, is represented by the following structural formula (I).

(I) 3−デオキシアフイデイコリンを生産するために使用さ
れる微生物は、通常てん菜じやのめ病菌として知られて
いる微生物で、ホマ・ベーテ(Phomabetae)
に属する菌株があげられる。
(I) The microorganism used to produce 3-deoxyaphuideicolin is a microorganism commonly known as sugar beet and soybean fungus, Phomabetae.
Examples include strains belonging to.

その代表的な菌株は、ホマ・ベーテ・フランクPS−1
3(PhomabetaeFrankPS−13)とし
て、工業技術院微生物工業技術研究所に寄託されている
(微工研菌寄第6556号)。本発明は、勿論自然界か
ら分離されるホマ・ベーテに属する微生物で、3−デオ
キシアフイデイコリンを生産する能力を有する菌株や、
紫外線、X線、放射線等の照射処理、N−メチルーN’
−ニトローN−ニトロングアニジン(NTG)、2−ア
ミノプリン等の化学薬剤等を用いて変異処理、接合等の
通常用いられる変異処理方法によつて生産能を高めた菌
株が包含される。ホマ・ベーテに属する3−デオキシア
フイデイコリン生産菌を栄養培地に培養することによつ
て j行われる3−デオキシアフイデイコリンの生産は
原則的には一般微生物の培養方法に準するが、通常は液
体培地による培養が行われる。
The representative strain is Homa Bethe Frank PS-1
3 (PhomabetaeFrankPS-13) and has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology (Feibokuken Bibori No. 6556). The present invention relates to a strain of microorganisms belonging to Homa Bethe isolated from the natural world and having the ability to produce 3-deoxyaphuideicolin,
Irradiation treatment with ultraviolet rays, X-rays, radiation, etc., N-methyl-N'
-Nitro N-Nitronguanidine (NTG), 2-aminopurine, and other chemical agents are used for mutation treatment, conjugation, and other commonly used mutation treatment methods to increase the production capacity are included. The production of 3-deoxyaphuideicolin, which is carried out by culturing 3-deoxyaphidicolin-producing bacteria belonging to Homa Bethe in a nutrient medium, is carried out in principle according to the culture method of general microorganisms, but usually is cultured in a liquid medium.

培養に用いられる培地としては、天然培地、半合成培地
あるいは合成培地が用いられる。培地組成としては、1
炭素源としてじやがいも煎汁、澱粉、デキストリン、グ
ルコース、シェークロース、グリセリン等が用いられ、
窒素源としてペプトン、肉工キズ、酵母工キズ、カゼイ
ン加水分解物、コーン・スチープ・ りカー、グノレテ
ンミーノレ、コーンミーノレ、l大豆粉、綿実粕、乾燥
酵母、硫酸アンモニウム、硝酸アンモニウム、尿素等が
用いられる。また、金属の塩類として炭酸カルシウム、
燐酸2水素力リウム、燐酸水素2カリウム、塩化マグネ
シウム等が適宜、添加される。培養温度は20〜30℃
前後が適当であり、培養容量が大きい場合には適宜種培
養を行つてこれを主培養に移植する方法をとる。
As the medium used for culture, a natural medium, a semi-synthetic medium, or a synthetic medium is used. The medium composition is 1
Potato decoction, starch, dextrin, glucose, shaken sugar, glycerin, etc. are used as carbon sources.
Nitrogen sources include peptone, meat scratches, yeast scratches, casein hydrolyzate, corn steep liquor, gnoretenmeal, cornmeal, soybean flour, cottonseed meal, dried yeast, ammonium sulfate, ammonium nitrate, urea, etc. used. In addition, calcium carbonate, metal salts,
Hydrogen dihydrogen phosphate, dipotassium hydrogen phosphate, magnesium chloride, etc. are added as appropriate. Culture temperature is 20-30℃
If the before or after is appropriate and the culture volume is large, a method is used in which a seed culture is performed as appropriate and then transplanted to the main culture.

本培養の培養期間は、培地の条件、培養の形式等により
異なり、たとえば静置培養で7 〜15日、通気攪拌培
養では50.〜200時間程度であつて、重要なことは
目的とする3−デオキシアフイデイコリンが培地中に実
質的な量が生産されるまで培養される。以上述べた培養
条件は使用菌株の特性に応じてそれぞれ最適の条件を選
択して適用される。
The culture period for main culture varies depending on the medium conditions, culture format, etc., and for example, 7 to 15 days for static culture, and 50 days for aerated agitation culture. The culture is carried out for approximately 200 hours, and importantly, until a substantial amount of the desired 3-deoxyaphidicolin is produced in the medium. The culture conditions described above are applied by selecting optimal conditions depending on the characteristics of the bacterial strain used.

上記の方法で培養物中に蓄積された3−デオキシアフイ
デイコリンは主に濾過プロス中に含有しているので、培
養液から菌体を除去した後、濾液から公知の分離・精製
手段を適宜選択組合わせて単離採取されるが、その一例
を示すと、次のとおりである。すなわち、培養濾液に氷
酢酸を加え、巾を5.5〜6.5とした後、減圧下で濃
縮し、これに目的物質3−デオキシアフイデイコリンを
溶解せしめる有機溶媒たとえば酢酸エチルを添加して抽
出する。ここで得られた抽出物(酢酸エチル層)を減圧
下で濃縮し、例えばシリカゲルのような吸着剤を用いた
クロマトグラフイ一にかける。吸着剤として、シリカゲ
ルを用いた場合には、溶出溶媒にクロロホルム、メタノ
ールの混合溶媒系を用いて溶出すると、溶出溶媒のフラ
クシヨン部分に、目的物質が溶出される。このようにし
て、培養液から目的物質3−デオキシアフイデイコリン
が単離採取される。なお、生産される3−デオキシアフ
イデイコリンの検出および定量は、シリカゲル薄層クロ
マトグラフイ一(タルク社製シリカゲル60F25,厚
さ0.2mm、展開溶媒;クロロホルムリメタノールニ
85:15,V/V,発色剤; 2,4−DNP試薬、
加熱)によつた。
Since 3-deoxyaphidicolin accumulated in the culture by the above method is mainly contained in the filtration process, after removing the bacterial cells from the culture solution, the filtrate is subjected to known separation and purification methods as appropriate. They are isolated and collected in selected combinations, an example of which is as follows. That is, after adding glacial acetic acid to the culture filtrate to make the width 5.5 to 6.5, it is concentrated under reduced pressure, and an organic solvent such as ethyl acetate that dissolves the target substance 3-deoxyaphidicolin is added thereto. Extract. The extract (ethyl acetate layer) obtained here is concentrated under reduced pressure and subjected to chromatography using an adsorbent such as silica gel. When silica gel is used as the adsorbent, when elution is performed using a mixed solvent system of chloroform and methanol as the elution solvent, the target substance is eluted in the fraction portion of the elution solvent. In this way, the target substance 3-deoxyaphidicolin is isolated and collected from the culture solution. Detection and quantification of the produced 3-deoxyafuidicorin was carried out using silica gel thin layer chromatography (silica gel 60F25 manufactured by Talc, thickness 0.2 mm, developing solvent: chloroformrimethanol, 85:15, V/ V, color former; 2,4-DNP reagent,
heating).

目的物質3−デオキシアフイデイコリンについて山 物
質の形状および色 白色針状結晶 (2)分析値(FD−マススペクトルおよびミリマスよ
り)C2OH34O3 (3)分子量(FD−マススペクトル) (4)融点 138.0〜140.5℃ (5)赤外線吸収スペクトル IR:゛Rcm−” 3350,2930,2850,
1440,1220,1030,750(6)核磁気共
鳴スペクトル ▲ ゜r、 .噌. , −K^八 ^轡一 /ハTT
^ 、工↓!ノ(7)溶解性 メタノール、エタノール、クロロホルム、酢酸エチルに
可溶、n−ヘキサンおよび水に不溶。
Regarding the target substance 3-deoxyafuidicorin Shape of the substance and white needle-like crystals (2) Analysis values (from FD-mass spectrum and millimas) C2OH34O3 (3) Molecular weight (FD-mass spectrum) (4) Melting point 138. 0 to 140.5°C (5) Infrared absorption spectrum IR: ゛Rcm-” 3350, 2930, 2850,
1440, 1220, 1030, 750 (6) Nuclear magnetic resonance spectrum ▲ ゜r, .噌. , -K^8 ^轡一 /HaTT
^, Engineering↓! (7) Solubility Soluble in methanol, ethanol, chloroform, ethyl acetate, insoluble in n-hexane and water.

(8)呈色反応 シリカゲル薄層クロマト上で゛アニスアルデヒドにより
ピック色を呈する。
(8) Color reaction Represents pick color on silica gel thin layer chromatography due to anisaldehyde.

上記の理化学的性状および別途研究の結果から目的物質
3−デオキシアフイデイコリンの構造は次のとおりであ
る。
Based on the above-mentioned physical and chemical properties and the results of separate research, the structure of the target substance 3-deoxyaphidicolin is as follows.

3−デオキシアフイデイコリンには、植物種子の生育阻
害作用、ウニ胚の卵割を抑制する作用等が認められ、D
NAポリメラーゼαの阻害活性も認められつつあり、そ
れらの阻害機構に関して詳細に明らかにされていないが
、新規な生理活性物質として重要視されている。
D
The inhibitory activity of NA polymerase α is also being recognized, and although the mechanism of inhibition has not been elucidated in detail, it is regarded as important as a new physiologically active substance.

次に、本発明の実施例を示す。Next, examples of the present invention will be shown.

実施例 1 ホマ・ベーテ・フランタ・PS−13株(PhOmab
etaeFrankPS−13;微工研菌寄第6556
号)を前培養培地に接種後、25℃,10日間培養を行
なつた。
Example 1 Homa Bethe Franta strain PS-13 (PhOmab
etaeFrankPS-13; Microtechnical Research Institute No. 6556
No.) was inoculated into the preculture medium, and then cultured at 25°C for 10 days.

ここに使用した前培養培地は、次の通りである。表皮を
剥いだじやがいも200gを1cm角に切り、水道水約
11を加え、オートクレーブ(1kg/Cm2,lO分
間)にて加熱処理し、煎汁をガーゼ4枚で淵過し、11
を得る。
The preculture medium used here is as follows. Cut 200 g of peeled potatoes into 1 cm cubes, add about 11 g of tap water, heat treat in an autoclave (1 kg/Cm2, lO min), strain the decoction through 4 pieces of gauze,
get.

これにシユータロース20g、粉末寒天20gを加え、
更に5分間オートタレーブにて加熱して溶解させる。次
に、前培養を行なつた種菌を、500m1容フラスコあ
たり150m1を分注殺菌した本培養培地に白金耳にて
接種し、25℃で15日間静置培養を行なつた。
Add 20g of shootalose and 20g of powdered agar to this,
The mixture is further heated in an autotable for 5 minutes to dissolve it. Next, 150 ml of the precultured inoculum was inoculated into a sterilized main culture medium per 500 ml flask using a platinum loop, and static culture was performed at 25° C. for 15 days.

ここで使用した本培養培地は、前培養培地より粉末寒天
を除いた培地である。培養終了後、淵過し、沢液13.
51を集め、氷酢酸を添加してIfI5.5〜6.5に
調整した。
The main culture medium used here is a medium obtained by removing powdered agar from the pre-culture medium. After completing the culture, filter and collect the sap 13.
51 was collected and the IfI was adjusted to 5.5-6.5 by adding glacial acetic acid.

この調整液を温度40℃以下で減圧下約1/6に濃縮し
た。この濃縮液に1.51の酢酸エチルを加え攪拌抽出
し、酢酸エチル層を分離した。こうして得られた酢酸エ
チル層を減圧下で濃縮乾固することにより、4.5gの
粗物質を得た。この粗物質4.5gをクロロホルムで充
填したシリカゲルカラム(和光純薬工業社製ワコーゲル
C一200を使用、以下同様、250g)にのせタロロ
ホルムにて展開し、次いでクロロホルムリメタノール(
98:2,VN)の混合溶媒にて展開、溶出液を1フラ
クシヨンあたり100m1づつ分画し、適宜シリカゲル
薄層クロマトグラフイ一(溶媒クロロホルムリメタノー
ル(85:15,/V)にて展開)にてRf値0.55
〜0.60の位置に検出・確認される目的物質の存在す
る画分(C−z)を集め、減圧下で濃縮乾固することに
より、3−デオキシアフイデイコリンを含む粉末211
mgを得た。
This adjusted solution was concentrated to about 1/6 under reduced pressure at a temperature of 40° C. or lower. To this concentrated solution, 1.51 ml of ethyl acetate was added and extracted with stirring, and the ethyl acetate layer was separated. The ethyl acetate layer thus obtained was concentrated to dryness under reduced pressure to obtain 4.5 g of crude material. 4.5 g of this crude material was placed on a silica gel column (Wako Gel C-200 manufactured by Wako Pure Chemical Industries, Ltd., 250 g) packed with chloroform and developed with taloloform, and then chloroformrimethanol (
Developed with a mixed solvent of 98:2, VN), fractionated the eluate into 100ml portions per fraction, and performed appropriate silica gel thin layer chromatography (developed with the solvent chloroformrimethanol (85:15, /V)) Rf value 0.55 at
The fraction (Cz) containing the target substance detected and confirmed at the position of ~0.60 was collected and concentrated to dryness under reduced pressure to obtain powder 211 containing 3-deoxyaphidicoline.
mg was obtained.

Claims (1)

【特許請求の範囲】 1 構造式( I ) ▲数式、化学式、表等があります▼ で示される3−デオキシアフイデイコリン。 2 ホマ・ベーテの3−デオキシアフイデイコリン生産
菌株を栄養培地に培養し、得られる培養物から3−デオ
キシアフイデイコリンを分離、採取することを特徴とす
る3−デオキシアフイデイコリンの製造法。 3 ホマ・ベーテが微工研菌寄第6556号と指定され
ている特許請求の範囲第2項記載の方法。
[Claims] 1. 3-deoxyaphidicoline represented by the structural formula (I) ▲ Numerical formulas, chemical formulas, tables, etc. are available▼. 2. A method for producing 3-deoxyaphidicolin, which comprises culturing a 3-deoxyaphidicolin-producing strain of Homa Bethe in a nutrient medium, and separating and collecting 3-deoxyaphidicolin from the resulting culture. . 3. The method according to claim 2, wherein Homa Bethe is designated as Kaikoken Bibori No. 6556.
JP10073082A 1982-06-14 1982-06-14 Novel physiologically active substance 3-deoxyafuidicorin and its production method Expired JPS5952000B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10073082A JPS5952000B2 (en) 1982-06-14 1982-06-14 Novel physiologically active substance 3-deoxyafuidicorin and its production method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10073082A JPS5952000B2 (en) 1982-06-14 1982-06-14 Novel physiologically active substance 3-deoxyafuidicorin and its production method

Publications (2)

Publication Number Publication Date
JPS58220689A JPS58220689A (en) 1983-12-22
JPS5952000B2 true JPS5952000B2 (en) 1984-12-17

Family

ID=14281716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10073082A Expired JPS5952000B2 (en) 1982-06-14 1982-06-14 Novel physiologically active substance 3-deoxyafuidicorin and its production method

Country Status (1)

Country Link
JP (1) JPS5952000B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS613898U (en) * 1984-06-12 1986-01-10 豊次 飯田 ladder step stool

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS613898U (en) * 1984-06-12 1986-01-10 豊次 飯田 ladder step stool

Also Published As

Publication number Publication date
JPS58220689A (en) 1983-12-22

Similar Documents

Publication Publication Date Title
CA1046439A (en) Physiologically active substances from penicillium citrinum
CA1335367C (en) Ks-506 compounds and process for the production thereof
JP2787446B2 (en) AB-006 antibiotic and method for producing the same
JPS5952000B2 (en) Novel physiologically active substance 3-deoxyafuidicorin and its production method
JPS6010720B2 (en) Production method of antibiotic C-15003 P-4
JPS58220690A (en) Preparation of aphidicolin and/or its derivative
JPS5951999B2 (en) New physiologically active substance betenone A and its production method
JP2676248B2 (en) L-carnitine production method
JPS5918037B2 (en) New physiologically active substance anthglutin and its production method
US5223637A (en) KS-506 compounds
JPH0220293A (en) Production of antitumor antibiotic ll-e33288 gamma 2
JPS5813395A (en) Preparation of cyclic-3',5'-guanylic acid
JPS5840475B2 (en) New physiologically active substance ML-236A and its manufacturing method
JPS5951998B2 (en) New physiologically active substance betenone B and its production method
JPH03279379A (en) New compound indanonaphthol a and b
JPS59166094A (en) Preparation of physiologically active substance ml-236b
EP0282322A2 (en) Novel serotonin inhibitors and pharmaceutical compositions containing them, and microbiological processes and organisms for the production thereof
JPH0272167A (en) Bu-3862t anti-tumor antibiotic
JPS5932120B2 (en) Method for producing 9-β-D arabinofuranosyl adenine
JPH0725878A (en) Platelet aggregation inhibitor pi-334
JPH0369894B2 (en)
JPS5830038B2 (en) Production method of coenzyme Q↓1↓0
JPH02221277A (en) New compound clodrimanine and production thereof
JPS6016594A (en) Preparation of menaquinone 6 by bacterium
JPS6016237B2 (en) Production method of antibiotic C-15003 P-2